Welcome to LookChem.com Sign In|Join Free
  • or
(4'-AMINO-BIPHENYL-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, also known as 4-Aminophenyl N-tert-butoxycarbonylcarbamate, is a white crystalline solid that serves as a tert-butyl ester derivative of biphenyl-4-ylcarbamic acid. It is predominantly utilized as a reagent in the realms of organic synthesis and pharmaceutical research, with potential applications in the creation of novel organic compounds and pharmaceutical intermediates. Due to its potential hazards when mishandled or exposed to certain conditions, it is crucial to handle (4'-AMINO-BIPHENYL-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER with caution.

206182-66-3

Post Buying Request

206182-66-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

206182-66-3 Usage

Uses

Used in Organic Synthesis:
(4'-AMINO-BIPHENYL-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a reagent for the synthesis of various organic compounds. Its unique structure allows it to participate in a range of chemical reactions, contributing to the formation of diverse molecules with potential applications in different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4'-AMINO-BIPHENYL-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a reagent for the development of pharmaceutical intermediates. These intermediates are essential building blocks in the synthesis of various drugs, making (4'-AMINO-BIPHENYL-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER a valuable asset in the creation of new medications.
Used in the Synthesis of Novel Compounds:
(4'-AMINO-BIPHENYL-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is also used as a reagent in the synthesis of novel organic compounds. Its involvement in chemical reactions can lead to the discovery of new molecules with unique properties and potential applications in various fields, such as materials science, chemical engineering, and environmental science.

Check Digit Verification of cas no

The CAS Registry Mumber 206182-66-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,1,8 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 206182-66:
(8*2)+(7*0)+(6*6)+(5*1)+(4*8)+(3*2)+(2*6)+(1*6)=113
113 % 10 = 3
So 206182-66-3 is a valid CAS Registry Number.

206182-66-3Relevant academic research and scientific papers

Synthesis of 4-benzidinyl butyric acid: A key intermediate for antibodies production against benzidin

Fischer-Durand, Nathalie,Rejeb, Samy Ben,Le Goffic, Francois

, p. 963 - 970 (1998)

A four-step synthesis of monoalkylated benzidin is reported for immunogen preparation against benzidin dye. Use of 10% H2SO4/dioxan for N- Boc cleavage avoids the cyclisation of 4-benzidinyl butyric acid into the corresponding lactam

Synthesis and Properties of Axially Symmetrical Rigid Visible Light-Harvesting Systems Containing [60]Fullerene and Perylenebisimide

Zhu, San-E,Liu, Kai-Qing,Wang, Xue-Fei,Xia, An-Dong,Wang, Guan-Wu

, p. 12223 - 12231 (2016)

Two visible light-harvesting perylenebisimide (PDI)-[60]fullerene (C60) systems, dyad P1 with one C60 unit and triad P2 with two C60 units, have been synthesized. Both systems are axially symmetrical with a rigid biphenyl linker, ensuring a relatively fixed spatial distance between the donor and acceptor, preventing through-space interaction, and enhancing energy transfer. Steady-state and transient spectroscopy, electrochemistry, as well as theoretical calculations have been used to investigate the electrochemical and photophysical properties of the two systems. Steady-state and time-resolved spectroscopy demonstrate that the excited state is featured by an efficient intramolecular energy transfer from PDI to C60. Then, the high efficient intrinsic intersystem crossing of C60 eventually leads to the production of the triplet C60. The extensive visible light absorption of PDI in the range of 400-650 nm and the final localization of the excited energy at the triplet C60 make these compounds ideal singlet oxygen inducers. Further investigation shows that the photooxidation capability for both compounds is significantly enhanced with respect to either PDI or C60 and even better than that of the commonly used triplet photosensitizer methylene blue (MB). The double C60 moieties in P2 display a better result, and the photooxidation efficiency of P2 increases 1.3- and 1.4-fold compared to that of P1 and MB, respectively. The combination of a light-harvesting unit with an intersystem crossing unit results in a highly efficient photooxidation system, which opens up a new way to triplet photosensitizer design.

A fullerene - perylene functional molecule and its preparation method

-

Paragraph 0030; 0034; 0035, (2017/06/02)

The invention discloses a fullerene-perylene functional molecule and a preparation method thereof, and relates to the technical field of design and synthesis of functional organic molecules. In a structural general formula, two fullerene pyrrole ring comp

Fullerene-perylene-boron dipyrromethene triplet-state photosensitive molecule and preparation method thereof

-

Paragraph 0046-0048, (2017/07/13)

The invention discloses a fullerene-perylene-boron dipyrromethene triplet-state photosensitive molecule and a preparation method thereof and relates to the technical field of design and synthesis of functional organic molecules. A fullerene perylene ring

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR

-

Paragraph 0704; 0705, (2016/08/17)

The present invention relates to bifunctional compounds, which find utility to degrade and (inhibit) Androgen Receptor. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds Androgen Receptor such that Androgen Receptor is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of Androgen Receptor. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of Androgen Receptor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 206182-66-3